Analystreport

AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) is now covered by analysts at B. Riley. They set a "buy" rating and a $9.00 price target on the stock.

AcelRx Pharmaceuticals, Inc.  (ACRX) 
Last acelrx pharmaceuticals, inc. earnings: 3/16 07:35 am Check Earnings Report
US:NASDAQ Investor Relations: ir.acelrx.com/investor-relations